Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Halozyme Therapeutics Inc. (HALO)

Index:

Nasdaq Composite

Add To Portfolio

$ 105.35

Change Today:

$-1.57
52 Week High: $109.29
52 Week Low: $61.70

Currency: US Dollars
Shares Issued: 145.30m
Volume: 1,681,929

Market Cap: $15,307m
RiskGrade: 189

Select chart: 1 year

1 year

Forecasts

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-26	1,777.13	1,018.48	814.17¢	12.9	n/a	n/a	n/a	0.0%
31-Dec-27	2,000.88	1,297.20	989.20¢	10.7	0.5	+22%	n/a	0.0%

Forecast Ratios

Year Ending	Revenue/Share	Price/Revenue per Share
31-Dec-26	$12.23	8.61
31-Dec-27	$13.77	7.65

Trends & Recommendations

	Current	1 week ago	1 month ago	3 months ago	6 months ago	1 year ago
Revenue ($m)
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	1,626
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	1,910

Earnings
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	791.50¢
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	965.00¢

Dividend
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	n/a
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	n/a

Recommendations
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Neutral	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
No. of Brokers	0	0	0	0	0	0

Average Rec	n/a	n/a	n/a	n/a	n/a	n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

HALO Market Data

Currency	US Dollars
Share Price	$ 105.35
Change Today	$ -1.57
% Change	-1.47 %
52 Week High	$109.29
52 Week Low	$61.70
Volume	1,681,929
Shares Issued	145.30m
Market Cap	$15,307m
RiskGrade	189